Synthetic biology startups dig for gold. Twist Bioscience is selling them millions of tiny shovels. Twist went public on October 30, 2019, at $14 a share. Since then, it has doubled to $28 dollars a share. Why has its stock doubled?
from https://ift.tt/2LGDKKH
No comments:
Post a Comment